Diversity in clinical trials is crucial to understanding how drugs and vaccines work and for improving their efficacy. Having diverse participants would not only increase the reliability of the data but could potentially address racial and gender gaps in medicine overall. Panelists will discuss the importance of diversifying clinical trials, the FDA's role in ensuring diversity, and the impact of COVID-19 on clinical trials, as well as related bioethics issues.
Journal of Gender, Social Policy & the Law
Office of Special Events